Delivery Order SPE2DB22D9239-SPE2DB24FDF13

Award Date 12/14/23
Potential Completion Date 1/8/24
Potential Value $144K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-eight thousand four hundred ninety-eight dollars and sixteen cents ($38,498.16) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceuticals and medical supplies to the Defense Logistics Agency, with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group will...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred forty-four thousand three hundred sixty-seven dollars and eighty cents ($144,367.80) by the Defense Logistics Agency. The delivery order was issued on November 6, 2023 under DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Specifically, this delivery order is for four hundred fifty-six...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 4562966584 units of Entyvio 300 mg vials. The $19,249.08 order has a completion date of December 14, 2023 and was awarded on November 22, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to supply pharmaceutical items and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $48,122.70 by the Defense Logistics Agency to provide 4562986926 units of Entyvio 300 mg vials. The delivery order was awarded on November 30, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand six dollars and seventy-five cents ($24,006.75) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this award, DMS Pharmaceutical Group will deliver VABYSMO 6 MG/0.05 ML vials...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product Entyvio. The potential value of this contract is $59,144.16, with a period of performance through January 25, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supports the Department of Defense by supplying a range of brand-name and generic...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,318.50 under the Defense Logistics Agency Troop Support Medical's indefinite delivery contract to provide pharmaceutical items. The order is for 8507864449 Typhoid VI Polysacc and requires completion by December 28, 2020. As a woman owned small business, DMS Pharmaceutical Group regularly supplies pharmaceuticals and medical products to support military treatment facilities for the Defense Logistics Agency...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at six thousand four hundred one dollars and eighty cents ($6,401.80) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 4562945987 units of Entyvio 300 mg vials. The $48,122.70 order has a completion date of December 18, 2023 and was awarded on November 27, 2023. DMS Pharmaceutical Group is a woman-owned small business and woman-owned business located in Park Ridge, Illinois that holds numerous contracts to supply pharmaceutical and medical products...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide one vial of Entyvio 300 mg for $38,498.08. Performance will be completed by December 18, 2023 at the place of performance in Park Ridge, Illinois. As a woman-owned small business, DMS Pharmaceutical Group regularly supplies pharmaceuticals and medical products to the Defense Logistics Agency in support of...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDF13
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred forty-four thousand three hundred sixty-seven dollars and eighty cents ($144,367.80) by the Defense Logistics Agency. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular award, DMS Pharmaceutical Group will provide forty-five hundred sixty-three vials of Entyvio, a medication used to treat ulcerative colitis and Crohn's disease, for distribution to Defense Logistics Agency Troop Support Medical locations. The contract contains no set-aside designation and requires completion by January 8, 2024. DMS Pharmaceutical Group will utilize its status as a woman-owned small business in fulfilling this delivery order for specialized pharmaceutical supplies to the Defense Logistics Agency.

Generated 3/14/24, 11:04 AM